Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 11

Results: 26

Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03834-y

By:

Chen, Ruxuan;
Shi, Yujie;
Fang, Nan;
Shao, Chi;
Huang, Hui;
Pan, Ruili;
Xu, Yan;
Wang, Mengqi;
Liu, Xiangning;
Xu, Kai;
Zhu, Rui;
Wang, Mengzhao

Publication type:

Article

Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03825-z

By:

Malhotra, Jyoti;
De, Subhajyoti;
Nguyen, Kim;
Lee, Percy;
Villaflor, Victoria

Publication type:

Article

Correction to: Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK‑mediated upregulation of PD‑L1.

Published in:

2024

By:

Zhang, Ruizhi;
Mao, Gan;
Tang, Yu;
Li, Chong;
Gao, Yisong;
Nie, Wenxiang;
Song, Tianyu;
Liu, Suao;
Zhang, Peng;
Tao, Kaixiong;
Li, Wei

Publication type:

Correction Notice

Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03820-4

By:

Xu, Jiao;
Yu, Bixin;
Wang, Fan;
Yang, Jin

Publication type:

Article

A monoclonal antibody recognizing CD98 on human embryonic stem cells shows anti-tumor activity in hepatocellular carcinoma xenografts.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03827-x

By:

Lim, Keunpyo;
Han, San Ha;
Han, Sein;
Lee, Ji Yoon;
Choi, Hong Seo;
Choi, Dongho;
Ryu, Chun Jeih

Publication type:

Article

Recent clinical researches and technological development in TIL therapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03793-4

By:

Matsueda, Satoko;
Chen, Lei;
Li, Hongmei;
Yao, Hui;
Yu, Fuli

Publication type:

Article

Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03826-y

By:

Guo, Jhe-Cyuan;
Huang, Ta-Chen;
Kuo, Hung-Yang;
Lin, Chia-Chi;
Hsu, Feng-Ming;
Cheng, Jason Chia-Hsien;
Huang, Yen-Lin;
Hsieh, Min-Shu;
Huang, Pei-Ming;
Lee, Jang-Ming;
Wu, Shu-Ling;
Hsu, Chih-Hung

Publication type:

Article

Disruptions in antigen processing and presentation machinery on sarcoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03822-2

By:

Renne, Salvatore Lorenzo;
Sama', Laura;
Kumar, Sonia;
Mintemur, Omer;
Ruspi, Laura;
Santori, Ilaria;
Sicoli, Federico;
Bertuzzi, Alexia;
Laffi, Alice;
Bonometti, Arturo;
Colombo, Piergiuseppe;
D'amato, Vittoria;
Bressan, Alessandra;
Scorsetti, Marta;
Terracciano, Luigi;
Navarria, Pierina;
D'incalci, Maurizio;
Quagliuolo, Vittorio;
Pasqualini, Fabio;
Grizzi, Fabio

Publication type:

Article

Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic ductal adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03821-3

By:

Yang, Shih-Hung;
Kuo, Sung-Hsin;
Lee, Jen-Chieh;
Chen, Bang-Bin;
Shan, Yan-Shen;
Tien, Yu-Wen;
Chiu, Sz-Chi;
Cheng, Ann-Lii;
Yeh, Kun-Huei

Publication type:

Article

Secretome and immune cell attraction analysis of head and neck cancers.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03809-z

By:

Muijlwijk, Tara;
Wondergem, Niels E.;
Ekhlas, Fatima;
Remkes, Naomi;
Nijenhuis, Dennis N. L. M.;
Fritz, Lennart;
Ganzevles, Sonja H.;
Miedema, Iris H. C.;
Leemans, C. René;
Poell, Jos B.;
Brakenhoff, Ruud H.;
van de Ven, Rieneke

Publication type:

Article

Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03818-y

By:

Quinn, Colin H.;
Julson, Janet R.;
Markert, Hooper R.;
Nazam, Nazia;
Butey, Swatika;
Stewart, Jerry E.;
Coleman, Jennifer C.;
Markert, James M.;
Leavenworth, Jianmei W.;
Beierle, Elizabeth A.

Publication type:

Article

Correction to: Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells.

Published in:

2024

By:

El-Seraf, Ibrahim;
Nilsson, Isabella Micallef;
Moter, Alina;
Duan, Zhe;
Mattsson, Jonas;
Magalhaes, Isabelle

Publication type:

Correction Notice

A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03810-6

By:

von der Grün, Jens;
Broglie, Martina;
Guckenberger, Matthias;
Balermpas, Panagiotis

Publication type:

Article

Immunogenomic features of radiologically distinctive nodules in multiple primary lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03807-1

By:

Chen, Mei-Cheng;
Yang, Hao-Shuai;
Dong, Zhi;
Li, Lu-Jie;
Li, Xiang-Min;
Luo, Hong-He;
Li, Qiong;
Zhu, Ying

Publication type:

Article

High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03799-y

By:

Hill, Samuel L.;
Sugiyarto, Gessa;
Harrington, Jack;
James, Edward;
Underwood, Timothy J.;
Elliott, Tim

Publication type:

Article

Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03805-3

By:

Kim, Jung Ho;
Hong, Jiyun;
Lee, Ji Ae;
Jung, Minsun;
Choi, Eunwoo;
Cho, Nam-Yun;
Kang, Gyeong Hoon;
Kim, Sangwoo

Publication type:

Article

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03804-4

By:

Zimmerman, Sarah M.;
Suh, Erin;
Smith, Sofia R.;
Souroullas, George P.

Publication type:

Article

The short-term efficacy of neoadjuvant SOX versus SOX plus immune checkpoint inhibitor following laparoscopic gastrectomy for locally advanced gastric cancer: a multicenter retrospective cohort study in China.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03802-6

By:

Cui, Hao;
Yang, Yongpu;
Song, Liqiang;
Yuan, Zhen;
Sun, Linde;
Du, Jiajun;
Lu, Yuyuan;
Ning, Ning;
Cui, Jianxin;
Shi, Yan;
Chen, Lin;
Wei, Bo

Publication type:

Article

Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03800-8

By:

Kawaguchi, Yo;
Okamoto, Keigo;
Kataoka, Yoko;
Shibata, Kohei;
Saito, Hiroki;
Shiratori, Takuya;
Ueda, Keiko;
Ohshio, Yasuhiko;
Hanaoka, Jun

Publication type:

Article

SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03806-2

By:

Li, Jin;
Bai, Yuxian;
Chen, Zhendong;
Ying, Jieer;
Guo, Yabing;
Fang, Weijia;
Zhang, Feng;
Xiong, Jianping;
Zhang, Tao;
Meng, Zhiqiang;
Zhang, Jingdong;
Ren, Zhenggang;
Hao, Chunyi;
Chen, Yajin;
Lin, Xiaoyan;
Pan, Hongming;
Zhou, Fuxiang;
Li, Xin;
Yu, Fan;
Zhang, Juan

Publication type:

Article

Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03798-z

By:

Mai, Zihang;
Kongjia, Luo;
Wang, Xinye;
Xie, Xiuying;
Pang, Lanlan;
Yang, Hong;
Wen, Jing;
Fu, Jianhua

Publication type:

Article

Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03797-0

By:

Yang, Dingyi;
Munai, Erha;
Zeng, Siwei;
Tao, Dan;
Yuan, Ze;
Du, Liang;
Zhou, Wei;
Wu, Yongzhong;
Zhu, Xiao-Dong

Publication type:

Article

Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03796-1

By:

Lu, Yunxin;
Jin, Yin;
Liu, Furong;
Wang, Zixian;
Zhou, Wen;
Zhang, Yang;
Bai, Bing;
Wang, Yun;
Wang, Zhiqiang;
Nie, Man;
Luo, Huiyan;
Wei, Xiaoli;
Liang, Chuqiao;
Guo, Guifang;
Qiu, Miaozhen;
Chen, Jianwen;
Liu, Yu;
Li, Shengping;
Li, Yuhong;
Wang, Fenghua

Publication type:

Article

Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03792-5

By:

Kikuchi, Ryota;
Watanabe, Yusuke;
Okuma, Takashi;
Nakamura, Hiroyuki;
Abe, Shinji

Publication type:

Article

Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrence.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03783-6

By:

Zhou, Danyang;
Li, Mei;
Wu, Wei;
Wu, Ying;
Nong, Qiaohong;
Wang, Shusen;
Hong, Ruoxi

Publication type:

Article

Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03781-8

By:

Murata, Daiki;
Azuma, Koichi;
Murotani, Kenta;
Kawahara, Akihiko;
Nishii, Yuuya;
Tokito, Takaaki;
Sasada, Tetsuro;
Hoshino, Tomoaki

Publication type:

Article